Corrigendum to "Biological effective dose is associated with radiological toxicity after lung stereotactic ablative radiation therapy" [Radiother. Oncol. 183 (2023) 109552].

MLA

Cases, Carla, et al. “Corrigendum to ‘Biological Effective Dose Is Associated with Radiological Toxicity after Lung Stereotactic Ablative Radiation Therapy’ [Radiother. Oncol. 183 (2023) 109552].” Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology, vol. 186, Sept. 2023, p. 109776. EBSCOhost, https://doi.org/10.1016/j.radonc.2023.109776.

APA

Cases, C., Benegas, M., Sánchez, M., Vollmer, I., Casas, F., Gomà, C., & Mollà, M. (2023). Corrigendum to “Biological effective dose is associated with radiological toxicity after lung stereotactic ablative radiation therapy” [Radiother. Oncol. 183 (2023) 109552]. Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology, 186, 109776. https://doi.org/10.1016/j.radonc.2023.109776

Chicago

Cases, Carla, Mariana Benegas, Marcelo Sánchez, Ivan Vollmer, Francesc Casas, Carles Gomà, and Meritxell Mollà. 2023. “Corrigendum to ‘Biological Effective Dose Is Associated with Radiological Toxicity after Lung Stereotactic Ablative Radiation Therapy’ [Radiother. Oncol. 183 (2023) 109552].” Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology 186 (September): 109776. doi:10.1016/j.radonc.2023.109776.